ESR1 and cervical carcinoma: In this retrospective study, we analyzed data in The Cancer Genome Atlas (TCGA) Pan-Cancer Atlas for ER expression and downstream signaling activity in breast, ovarian, endometrial, and cervical cancer patients to elucidate the differences in ER cell signaling and survival among these four cancers [25, 26].